BioWorld Science

Aug. 17, 2020

View Archived Issues

Stromal cell subtypes identified in TNBC

Read More

From variants to treatments in neurology

Read More

New selective NKCC1 inhibitor for neurological conditions with impaired chloride ion homeostasis

Read More

LION/repRNA-CoV2S vaccine candidate shows efficacy in vivo

Read More

Phase III data presented for incobotulinumtoxin A in post-stroke upper-limb spasticity

Read More

Beijing Scitech-Mq Pharmaceuticals patents multitarget inhibitors

Read More

New phosphodiesterase PDE3A and PDE3B inhibitors disclosed by Bayer, The Broad Institute

Read More

Medshine Discovery discovers PD-L1 expression inhibitors

Read More

Jiangsu Hansoh Pharmaceutical, Shanghai Hansoh Biomedical identify agents targeting 5-HT2A/DRD3

Read More

Aeovian Pharmaceuticals identifies new mTORC1 inhibitors

Read More

Vivozon halts phase III study of opiranserin due to COVID-19 outbreak in the U.S.

Read More

Homozygous mutations in BTG4 are responsible for the phenotype of zygotic cleavage failure

Read More

FDA approves Enspryng for neuromyelitis optica spectrum disorder

Read More

Missense variants in the TRIP13 gene cause oocyte meiotic arrest resulting in female infertility

Read More

Discovery of autoantibody biomarkers for SLE diagnosis using a 2-phase proteome microarray strategy

Read More

Dosing initiates in phase IIa study of ASC-22 in patients with chronic hepatitis B

Read More

Starpharma and Chase Sun to develop novel DEP nanoparticle formulations

Read More

Specific miRNA-1 oxidation encodes cardiac hypertrophy

Read More

Kiadis announces K-NK-cell technology program for the development of COVID-19 therapy

Read More

Novavax initiates phase IIb efficacy trial of NVX-CoV2373 in South Africa

Read More